(688056)"Beijing LabTech Instruments Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688056 · · 2 pages · Chinese
Summary by 6ix AI
The company aims to address investor questions regarding its financial results and operational performance during this session. Participants will include key executives such as the chairman and general manager.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beijing Labtech Instruments Co. Ltd. on 6ix
Story so far
- (688056)"Beijing LabTech Instruments Co., Ltd."Announcement on Early Termination of Shareholding Reduction Plan by Shareholder
- (688056)"Beijing LabTech Instruments Co., Ltd."Announcement on Extension of Certain Raised Funds Investment Projects
- (688056)"Beijing LabTech Instruments Co., Ltd."Announcement on Completion of Certain Raised Funds Investment Projects and Permanent Supplementation of Working Capital with Surplus Raised Funds
Earlier from Beijing Labtech Instruments
- (688056)"Beijing LabTech Instruments Co., Ltd."Announcement on Early Termination of Shareholding Reduction Plan by Shareholder
- (688056)"Beijing LabTech Instruments Co., Ltd."Report for Q3 2026
- (688056)"Beijing LabTech Instruments Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026
- (688056)"Beijing LabTech Instruments Co., Ltd."Announcement on Resolutions of the 11th Meeting of the 5th Board of Directors
- (688056)"Beijing LabTech Instruments Co., Ltd."Announcement on Extension of Certain Raised Funds Investment Projects
Follow Beijing Labtech Instruments into a list and get an email when it puts out news.
Follow Beijing Labtech Instruments